Stoke Therapeutics Inc Live Share Price Today, Share Analysis and Chart

Name: Stoke Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: Stoke Therapeutics Inc
Rating: 2.393444375
Author: Trendlyne DVM scores

Mid-range Performer

about

Stoke Therapeutics Inc is a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine. Its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, Stoke is developing antis...

11.75 -0.31 (-2.57%)

27.24% Fall from 52W High

535.0K

XNAS Volume

XNAS 15 Jul, 2025 5:30 PM (EDT)

Medium Financial Strength

44.4 / 100

Mid Valuation

44.2 / 100

Technically Neutral

58.4 / 100

Mid-range Performer These stocks average quality, financial and technical aspects make them being considered by the investor who are not looking for high risk stocks. View Similar Embed DVM

1Yr Price target upside is 90%

8 analysts

Stoke Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Stoke Therapeutics Inc Live Share Price Today, Share Analysis and Chart

Stoke Therapeutics Inc is a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine. Its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, Stoke is developing antis...

27.24% Fall from 52W High

SWOT Analysis

Stoke Therapeutics Inc Live Price Chart